Usage of this drug is indicated in the treatment of upper respiratory tract infections such as pneumonia, intra-abdominal infections, and skin structure-associated infections both complicated and uncomplicated in nature, and intra-abdominal infections.

Mild to moderate side effects have been observed. Side effects such as nausea, rashes, neutropenia, apnea, glossitis, pruritus, thrombocytopenia, and elevated liver function tests.

To be prescribed cautiously in patients with a history of disorders of the central nervous system such as seizures, toxic epidermal necrolysis, Steven Johnson syndrome, Erythema multiforme, and allergic reactions.

This drug is contraindicated in patients with a known history of hypersensitivity to this drug or drugs from this class.

In adults, the usual dosage consists of 500 mg I.V. over eight hours; the dose should not exceed 2 g I.V. eight hours.

We have also established roots and begun this new venture in other countries as well, such as Cape Verde, Mongolia, Japan, Brunei, Laos, and Aruba.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai